Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone
2012 ◽
Vol 118
(22)
◽
pp. 5709-5718
◽
Joel B. Nelson
◽
Karim Fizazi
◽
Kurt Miller
◽
Celestia Higano
◽
Judd W. Moul
◽
...
Bruno Andreoni
◽
Gianmarco Contino
2019 ◽
Vol 201
(Supplement 4)
◽
Fred Saad*
◽
Cora N. Sternberg
◽
Eleni Efstathiou
◽
Karim Fizazi
◽
Katharina Modelska
◽
...
2021 ◽
Vol 398
(10295)
◽
pp. 131-142
Christopher Sweeney
◽
Sergio Bracarda
◽
Cora N Sternberg
◽
Kim N Chi
◽
David Olmos
◽
...
2017 ◽
Vol 71
(2)
◽
pp. 151-154
◽
Tomasz M. Beer
◽
Andrew J. Armstrong
◽
Dana Rathkopf
◽
Yohann Loriot
◽
Cora N. Sternberg
◽
...
2019 ◽
Vol 75
(6)
◽
pp. 929-937
◽
Ethan M. Basch
◽
Mark Scholz
◽
Johann S. de Bono
◽
Nicholas Vogelzang
◽
Paul de Souza
◽
...
Fred Saad
◽
Neal D Shore
◽
Hendrik Van Poppel
◽
Dana Rathkopf
◽
Matthew R. Smith
◽
...
2018 ◽
Vol 36
(5)
◽
pp. 919-926
◽
Paul Monk
◽
Glenn Liu
◽
Walter M. Stadler
◽
Susan Geyer
◽
Ying Huang
◽
...
2019 ◽
Vol 20
(4)
◽
pp. 556-569
◽
Bertrand Tombal
◽
Fred Saad
◽
David Penson
◽
Maha Hussain
◽
Cora N Sternberg
◽
...